FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems
FGK Clinical Research GmbH has entered into a multi-year partnership with OmniComm Systems, Inc. Under the terms of the agreement, FGK will use TrialMaster electronic data capture , IRTMaster, and Acuity Analytics along with other related products/services to supplement FGK’s clinical trial operational and data management services.
To learn more, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
